Evidence map›Paper›PMID 42783337›Full record

ReviewInsects2026

Exploring and Mitigating Insecticide Resistance in Urban Pests with New Synergists and Insecticides.

Ayashaa Ahmad, Vartul Panhalkar, Manas Sarkar, Jeffrey Bloomquist

Abstract readReview
In one paragraph

Review in Insects, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayashaa AhmadDepartment of Research and Development, Vestacy (E.H. Entomology India Pvt. Ltd.), D-30, Infocity II, Sector 33, Gurgaon 122001, India.
Vartul PanhalkarGerm Protection-Bar Soap Delivery, Research & Development, Reckitt Benckiser India Pvt. Ltd., Infocity II, Sector 33, Gurgaon 122001, India.
Manas SarkarDepartment of Research and Development, Vestacy (E.H. Entomology India Pvt. Ltd.), D-30, Infocity II, Sector 33, Gurgaon 122001, India.
Jeffrey BloomquistEmerging Pathogens Institute, Entomology and Nematology Department, University of Florida, Gainesville, FL 32610, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review summarizes the impact of insecticide resistance in urban pests and its implications for 'One Health' systems. Mosquitoes are the major vector of human disease via blood feeding, followed by houseflies and cockroaches via physical contact, and finally bed bugs, ants, and termites, which are not typically disease vectors. Besides overt disease, other impacts in the context of One Health include nuisance biting and resultant infections, as well as allergic reactions. Control of urban pests is still primarily achieved with insecticides, which have continually improved over time. However, their use has selected for the evolution of resistance to several compound classes across broad geographical areas and multiple species. Resistance results from several types of mechanisms: altered inherited behavioral repertoires that reduce chemical exposure, modified target sites, increased metabolism, and reduced penetration, which have recently been shown to have several specific underlying causes. Overall, the literature portrays a complex resistance landscape that highlights the importance of comprehensive, multifaceted approaches to maintain effective control. New technologies and approaches for resistance management are also discussed, with emphasis on improved chemical control measures via novel synergists and insecticides from both natural and synthetic sources.

Indexed as

bed bugcockroachhouseflyinsecticidemosquitosynergist

Identifiers

PMID42783337
PMCPMC13607387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.